Authorship: Authors are responsible for the whole content of each article. Co-authorship should be based on the following 4 criteria: (1) substantial contributions to the conception or designing of the work; or the acquisition, analysis, or interpretation of data for the work; (2) drafting or revising of the work critically for important intellectual content; (3) final approval of the version to be published; and (4) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Participation solely in the acquisition of funding or the collection of data does not justify authorship and, except in the case of complex large-scale or multi-centre research, the number of authors should usually not exceed six.Any persons who do not meet the 4 criteria above should be placed as contributors in Acknowledgments section.

Acknowledgements: Under Acknowledgements please specify contributors to the article other than the authors accredited.

When experimental animals are used the methods section must clearly indicate that adequate measures were taken to minimize pain or discomfort. Experiments should be carried out in accordance with the Guidelines laid down by the National Institute of Health (NIH) in the USA regarding the care and use of animals for experimental procedures or with the European Communities Council Directive of 24 November 1986 (86/609/EEC) and in accordance with local laws and regulations.

The Journal reserves the right to reject any paper where there is reason to believe that animals have been subjected to unnecessary or avoidable pain or distress. Where animals have been used in a study, the relevant research ethical or animal welfare or institutional review authority, under which the work was conducted, must be stated. Furthermore, manuscripts describing prospective studies involving client-owned animals should also include documentation of informed client consent.

Ethics of investigation: Papers not in agreement with the guidelines of the 1975 Helsinki Declaration as revised in 2013 will not be accepted for publication (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/).

Research and publication ethics
Duplicate Publication: Redundant publication is defined as “reporting (publishing or attempting to publish) substantially the same work more than once, without attribution of the original source(s).” Characteristics of reports that are substantially similar include the following: (a) “at least one of the authors must be common to all reports (if there are no common authors, it is more likely plagiarism than redundant publication),” (b) “the subjects or study populations are the same or overlapped,” (c) “the methodology is typically identical or nearly so,” and (d) “the results and interpretation have little or no variations.” When submitting a manuscript, authors should include a letter informing the editor of any potential overlap with other already published material or material being evaluated for publication and should also state how the manuscript submitted to Ann Dermatol differs substantially from this other material. If all or part of the patient population was previously reported, this should be mentioned in the Materials and Methods section, with citations of the appropriate reference(s).

Clinical trials: randomized clinical trials (RCTs) and systematic reviews should be reported according to the CONSORT guidelines available at www.consort-statement.org A CONSORT checklist should be used as a guide before submission of material (CONSORT statement).
Registration of Clinical Trial Research: It is recommended that any research dealing with a clinical trial be registered with a primary national clinical trial registration site such as Clinical Research Information Service (https://cris.nih.go.kr/cris/index.jsp), or other sites accredited by the World Health Organization ICTRP (https://www.who.int/ictrp/en/) and ClinicalTrials.gov (https://clinicaltrials.gov/), a service of the United States National Institutes of Health.

This journal follows the data sharing policy described in “Data Sharing Statements for Clinical Trials: A Requirement of the International Committee of Medical Journal Editors”. The ICMJE’s policy regarding trial registration is explained at http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html#two. If the data sharing plan changes after registration this should be reflected in the statement submitted and published with the manuscript, and updated in the registry record.

Papers reporting protein or DNA sequences will not be accepted without a GenBank accession number. Other supporting data sets must be made available on the publication date from the authors directly.

Conflict of Interest: Authors are required to disclose any possible conflict of interest. These include financial (for example patent, ownership, stock ownership, consultancies, speaker’s fee). Author’s conflict of interest (or information specifying the absence of conflicts of interest) will be published under a separate heading entitled Conflict of Interest. Journal of Veterinary Clinics requires that sources of institutional, private and corporate financial support for the work within the manuscript must be fully acknowledged, and any potential conflicts of interest noted. This information is a requirement for all manuscripts submitted to the Journal and will be published in a highlighted box on the title page of the article. Please include this information under the separate headings of ‘Source of Funding’ and ‘Conflict of Interest’ immediately after the abstract section of your manuscript. If the author does not include a conflict of interest statement in the manuscript then the following statement will be included by default: ‘No conflicts of interest have been declared’.

If the whole or part(s) of previously published illustrations are used, permission must be obtained from the copyright holder concerned. It is the author’s responsibility to obtain these in writing and provide copies to the Publishers.

Authors submitting a paper do so on the understanding that the work and its essential substance have not been published before and is not being considered for publication elsewhere. Presentation or publication of part or all of the data in, for instance, congress proceedings, should be clearly declared when the paper is submitted.

The submission of the manuscript by the authors means that the authors automatically agree to assign exclusive license/copyright to The Korean Society of Veterinary Clinics if and when the manuscript is accepted for publication. The work shall not be published elsewhere in any language without the written consent of the publisher. The articles published in this journal are protected by copyright, which covers translation rights and the exclusive right to reproduce and distribute all of the articles printed in the journal. No material published in the journal may be stored on microfilm or videocassettes, in electronic databases and the like, or reproduced photographically without the prior written permission of the publisher.

Correspondence to the journal is accepted on the understanding that the contributing author licenses the publisher to publish the letter as part of the journal or separately from it, in the exercise of any subsidiary rights relating to the journal and its contents.

Upon acceptance of a paper, authors are required to assign the exclusive license to publish their paper to The Korean Society of Veterinary Clinics. Assignment of the exclusive license is a condition of publication and papers will not be passed to the publisher for production unless a license has been assigned. (Papers subject to government or Crown copyright are exempt from this requirement; however, the form still has to be signed). A completed Exclusive License Form must be sent to the address specified on the form, before any manuscript can be published. Authors must send the completed original Exclusive License Form by regular mail upon receiving notice of manuscript acceptance, i.e., do not send the form at submission. Faxing or e-mailing the form does not meet the requirements.

This journal is an open access journal distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided that the original work is properly cited. Author(s) do not need to be permitted for use of tables or figures published in Journal of Veterinary Clinics in other journals, books, or media for scholarly and educational purposes. This is in accordance with the Budapest Open Access Initiative definition of open access.

For questions concerning copyright, please visit Copyright FAQs

Animal experiments are to be undertaken only with the purpose of advancing knowledge and in a manner that avoids unnecessary discomfort to the animals by the use of proper management and laboratory techniques. They shall be conducted in compliance with federal, state and local laws and regulations, and in accordance with the internationally accepted principles and guidelines for the care and use of agricultural, laboratory or experimental animals.

In the interests of the reproducibility of results, accurate information about any test animals used in the experiments (origin,inbreeding etc.), as well as information about the housing conditions (diet, environment etc.), should be given.

The editors and the publisher endeavor to publish all articles as rapidly as possible and in the best possible typographical condition. They request that all authors observe carefully the recommendations laid down in these Instructions for Authors.